Assyro AI

FDA Orange Book · active-ingredient family

Codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride

Codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · syrup

ProductApplicantApplicationTEApproved
PHENERGAN VC W/ CODEINERLDANI PHARMSNDA 008306Apr 02, 1984

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATEAMNEAL PHARMSANDA 200963AAAug 26, 2015
PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATEHIKMAANDA 040674Dec 23, 2014
PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATEPAI HOLDINGSANDA 040660AADec 07, 2006
PHERAZINE VC W/ CODEINEHALSEYANDA 088870Mar 02, 1987
PROMETHAZINE VC W/ CODEINECENCIANDA 088816Nov 22, 1985
PROMETHAZINE VC W/ CODEINEWOCKHARDTANDA 088896Jan 04, 1985
PROMETH VC W/ CODEINECHARTWELL RXANDA 088764Oct 31, 1984

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.